The registration for clinical trials on the antiviral drug Remdesivir has been approved

The registration for clinical trials on the antiviral drug Remdesivir has been approved



Good news! The registration for clinical trials on the antiviral drug Remdesivir has been approved, and the first batch of pneumonia patients infected by the novel coronavirus are expected to start taking the drug Thursday xhne.ws/lLKZ2

#coronoavirus #WuhanCoronavirus #WuhanChina

source

Leave a Reply

Your email address will not be published.